Literature DB >> 28242452

Top-down analysis of immunoglobulin G isotypes 1 and 2 with electron transfer dissociation on a high-field Orbitrap mass spectrometer.

Luca Fornelli1, Daniel Ayoub1, Konstantin Aizikov2, Xiaowen Liu3, Eugen Damoc2, Pavel A Pevzner4, Alexander Makarov2, Alain Beck5, Yury O Tsybin6.   

Abstract

The increasing importance of immunoglobulins G (IgGs) as biotherapeutics calls for improved structural characterization methods designed for these large (~150kDa) macromolecules. Analysis workflows have to be rapid, robust, and require minimal sample preparation. In a previous work we showed the potential of Orbitrap Fourier transform mass spectrometry (FTMS) combined with electron transfer dissociation (ETD) for the top-down investigation of an intact IgG1, resulting in ~30% sequence coverage. Here, we describe a top-down analysis of two IgGs1 (adalimumab and trastuzumab) and one IgG2 (panitumumab) performed with ETD on a mass spectrometer equipped with a high-field Orbitrap mass analyzer. For the IgGs1, sequence coverage comparable to the previous results was achieved in a two-fold reduced number of summed transients, which corresponds, taken together with the significantly increased spectra acquisition rate, to ~six-fold improvement in analysis time. Furthermore, we studied the influence of ion-ion interaction times on ETD product ions for IgGs1, and the differences in fragmentation behavior between IgGs1 and IgG2, which present structural differences. Overall, these results reinforce the hypothesis that gas phase dissociation using both energy threshold-based and radical-driven ion activations is directed to specific regions of the polypeptide chains mostly by the location of disulfide bonds. SIGNIFICANCE OF THE STUDY: Compared with our previous report, the results presented herein demonstrate the power of technological advances of the next generation Orbitrap™ platform, including the use of a high-field compact (i.e., D20) Orbitrap mass analyzer, and a dedicated manipulation strategy for large protein ions (via their trapping in the HCD collision cell along with reduction of the pressure in the cell). Notably, these important developments became recently commercially available in the top-end Orbitrap platforms under the name of "Protein Mode". Furthermore, we continued exploring the advantages offered by the summation (averaging) of transients (time-domain data) for improving the signal-to-noise ratio of top-down mass spectra. Finally, for the first time we report the application of the hybrid ion activation technique that combines electron transfer dissociation and higher energy collisional dissociation, known as EThcD, on intact monoclonal antibodies. Under these specific instrumental parameters, EThcD produces a partially complementary fragmentation pattern compared to ETD, increasing the overall sequence coverage especially at the protein termini.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electron transfer dissociation, ETD; Immunoglobulin G, IgG; Orbitrap; Top-down

Mesh:

Substances:

Year:  2017        PMID: 28242452      PMCID: PMC5478168          DOI: 10.1016/j.jprot.2017.02.013

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  47 in total

1.  Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis.

Authors:  Oleg V Krokhin; Mihaela Antonovici; Werner Ens; John A Wilkins; Kenneth G Standing
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

Review 2.  Mass spectrometry for structural characterization of therapeutic antibodies.

Authors:  Zhongqi Zhang; Hai Pan; Xiaoyu Chen
Journal:  Mass Spectrom Rev       Date:  2009 Jan-Feb       Impact factor: 10.946

3.  Unit mass baseline resolution for an intact 148 kDa therapeutic monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Santosh G Valeja; Nathan K Kaiser; Feng Xian; Christopher L Hendrickson; Jason C Rouse; Alan G Marshall
Journal:  Anal Chem       Date:  2011-10-20       Impact factor: 6.986

4.  Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry.

Authors:  Christian K Frese; A F Maarten Altelaar; Henk van den Toorn; Dirk Nolting; Jens Griep-Raming; Albert J R Heck; Shabaz Mohammed
Journal:  Anal Chem       Date:  2012-10-31       Impact factor: 6.986

5.  Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry.

Authors:  Bo Wang; Ashley C Gucinski; David A Keire; Lucinda F Buhse; Michael T Boyne
Journal:  Analyst       Date:  2013-05-21       Impact factor: 4.616

6.  Biopharmaceutical benchmarks 2014.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2014-10       Impact factor: 54.908

7.  Front-end electron transfer dissociation: a new ionization source.

Authors:  Lee Earley; Lissa C Anderson; Dina L Bai; Christopher Mullen; John E P Syka; A Michelle English; Jean-Jacques Dunyach; George C Stafford; Jeffrey Shabanowitz; Donald F Hunt; Philip D Compton
Journal:  Anal Chem       Date:  2013-08-19       Impact factor: 6.986

8.  Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides.

Authors:  Lawrence W Dick; Catherine Kim; Difei Qiu; Kuang-Chuan Cheng
Journal:  Biotechnol Bioeng       Date:  2007-06-15       Impact factor: 4.530

Review 9.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

10.  Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques.

Authors:  Daniel Ayoub; Wolfgang Jabs; Anja Resemann; Waltraud Evers; Catherine Evans; Laura Main; Carsten Baessmann; Elsa Wagner-Rousset; Detlev Suckau; Alain Beck
Journal:  MAbs       Date:  2013-06-20       Impact factor: 5.857

View more
  19 in total

1.  A comprehensive pipeline for translational top-down proteomics from a single blood draw.

Authors:  Timothy K Toby; Luca Fornelli; Kristina Srzentić; Caroline J DeHart; Josh Levitsky; John Friedewald; Neil L Kelleher
Journal:  Nat Protoc       Date:  2019-01       Impact factor: 13.491

2.  A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.

Authors:  Oscar Hernandez-Alba; Stéphane Houel; Steve Hessmann; Stéphane Erb; David Rabuka; Romain Huguet; Jonathan Josephs; Alain Beck; Penelope M Drake; Sarah Cianférani
Journal:  J Am Soc Mass Spectrom       Date:  2019-08-19       Impact factor: 3.109

3.  Thorough Performance Evaluation of 213 nm Ultraviolet Photodissociation for Top-down Proteomics.

Authors:  Luca Fornelli; Kristina Srzentić; Timothy K Toby; Peter F Doubleday; Romain Huguet; Christopher Mullen; Rafael D Melani; Henrique Dos Santos Seckler; Caroline J DeHart; Chad R Weisbrod; Kenneth R Durbin; Joseph B Greer; Bryan P Early; Ryan T Fellers; Vlad Zabrouskov; Paul M Thomas; Philip D Compton; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2019-12-30       Impact factor: 5.911

Review 4.  Top-Down Proteomics: Ready for Prime Time?

Authors:  Bifan Chen; Kyle A Brown; Ziqing Lin; Ying Ge
Journal:  Anal Chem       Date:  2017-12-15       Impact factor: 6.986

5.  Proton Transfer Charge Reduction Enables High-Throughput Top-Down Analysis of Large Proteoforms.

Authors:  Romain Huguet; Christopher Mullen; Kristina Srzentić; Joseph B Greer; Ryan T Fellers; Vlad Zabrouskov; John E P Syka; Neil L Kelleher; Luca Fornelli
Journal:  Anal Chem       Date:  2019-11-22       Impact factor: 6.986

6.  Accurate Sequence Analysis of a Monoclonal Antibody by Top-Down and Middle-Down Orbitrap Mass Spectrometry Applying Multiple Ion Activation Techniques.

Authors:  Luca Fornelli; Kristina Srzentić; Romain Huguet; Christopher Mullen; Seema Sharma; Vlad Zabrouskov; Ryan T Fellers; Kenneth R Durbin; Philip D Compton; Neil L Kelleher
Journal:  Anal Chem       Date:  2018-06-28       Impact factor: 6.986

7.  Sequencing Larger Intact Proteins (30-70 kDa) with Activated Ion Electron Transfer Dissociation.

Authors:  Nicholas M Riley; Michael S Westphall; Joshua J Coon
Journal:  J Am Soc Mass Spectrom       Date:  2017-10-12       Impact factor: 3.109

8.  Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.

Authors:  Jean M Lodge; Kevin L Schauer; Dain R Brademan; Nicholas M Riley; Evgenia Shishkova; Michael S Westphall; Joshua J Coon
Journal:  Anal Chem       Date:  2020-07-16       Impact factor: 6.986

9.  Novel Interface for High-Throughput Analysis of Biotherapeutics by Electrospray Mass Spectrometry.

Authors:  Hae-Min Park; Valerie J Winton; Jared J Drader; Sheri Manalili Wheeler; Greg A Lazar; Neil L Kelleher; Yichin Liu; John C Tran; Philip D Compton
Journal:  Anal Chem       Date:  2020-01-10       Impact factor: 6.986

10.  Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry.

Authors:  Kristina Srzentić; Luca Fornelli; Yury O Tsybin; Joseph A Loo; Henrique Seckler; Jeffrey N Agar; Lissa C Anderson; Dina L Bai; Alain Beck; Jennifer S Brodbelt; Yuri E M van der Burgt; Julia Chamot-Rooke; Sneha Chatterjee; Yunqiu Chen; David J Clarke; Paul O Danis; Jolene K Diedrich; Robert A D'Ippolito; Mathieu Dupré; Natalia Gasilova; Ying Ge; Young Ah Goo; David R Goodlett; Sylvester Greer; Kim F Haselmann; Lidong He; Christopher L Hendrickson; Joshua D Hinkle; Matthew V Holt; Sam Hughes; Donald F Hunt; Neil L Kelleher; Anton N Kozhinov; Ziqing Lin; Christian Malosse; Alan G Marshall; Laure Menin; Robert J Millikin; Konstantin O Nagornov; Simone Nicolardi; Ljiljana Paša-Tolić; Stuart Pengelley; Neil R Quebbemann; Anja Resemann; Wendy Sandoval; Richa Sarin; Nicholas D Schmitt; Jeffrey Shabanowitz; Jared B Shaw; Michael R Shortreed; Lloyd M Smith; Frank Sobott; Detlev Suckau; Timothy Toby; Chad R Weisbrod; Norelle C Wildburger; John R Yates; Sung Hwan Yoon; Nicolas L Young; Mowei Zhou
Journal:  J Am Soc Mass Spectrom       Date:  2020-08-19       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.